Jie Chen
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- RNA Interference and Gene Delivery 65
- Advanced biosensing and bioanalysis techniques 55
-
- Nanoplatforms for cancer theranostics 59
- Co-authors
- Huayu Tian (83 shared papers)Xuesi Chen (75 shared papers)Zhaopei Guo (42 shared papers)Lin Lin (20 shared papers)Lin Lın (20 shared papers)Jiayan Wu (18 shared papers)Xiuwen Guan (7 shared papers)Yingying Hu (13 shared papers)
- Journals
- Journal of Controlled Release (10 papers)Macromolecular Bioscience (7 papers)ACS Applied Materials & Interfaces (7 papers)Dalton Transactions (5 papers)Advanced Materials (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jie Chen
266 papers receiving 8.7k citations
Jie Chen's Hit Papers
Peers
Comparison fields: 5 of 163
- Biomaterials 1.6k
- Biomedical Engineering 3.2k
- Molecular Biology 3.5k
- Immunology 962
- Cancer Research 491
Countries citing papers authored by Jie Chen
This map shows the geographic impact of Jie Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Chen more than expected).
Fields of papers citing papers by Jie Chen
This network shows the impact of papers produced by Jie Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Chen. The network helps show where Jie Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 275 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer Hit paper breakdown → | 2017 | 417 |
| 2 | 2001 | 302 | |
| 3 | 2016 | 234 | |
| 4 | 2016 | 185 | |
| 5 | 2013 | 183 | |
| 6 | 2020 | 178 | |
| 7 | Biomineralized Two‐Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy Hit paper breakdown → | 2022 | 169 |
| 8 | 2018 | 146 | |
| 9 | 2017 | 138 | |
| 10 | 2018 | 128 | |
| 11 | 2011 | 127 | |
| 12 | 2017 | 127 | |
| 13 | 2013 | 126 | |
| 14 | 2019 | 124 | |
| 15 | 2018 | 116 | |
| 16 | 1994 | 111 | |
| 17 | 2020 | 110 | |
| 18 | 2011 | 107 | |
| 19 | 2022 | 104 | |
| 20 | 2018 | 100 |
About Jie Chen
Jie Chen is a scholar working on Molecular Biology, Biomedical Engineering, Immunology, Genetics and Materials Chemistry, having authored 275 papers that have together received 8.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (65 papers), Nanoplatforms for cancer theranostics (59 papers), Advanced biosensing and bioanalysis techniques (55 papers), Virus-based gene therapy research (28 papers), Immunotherapy and Immune Responses (26 papers), Nanoparticle-Based Drug Delivery (19 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Cancer Research and Treatments (13 papers). The work is most often cited by research in Biomaterials (1.6k citations), Biomedical Engineering (3.2k citations), Molecular Biology (3.5k citations), Immunology (962 citations) and Cancer Research (491 citations). Jie Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Huayu Tian, Xuesi Chen, Zhaopei Guo, Lin Lin, Lin Lın, Jiayan Wu, Xiuwen Guan, Yingying Hu, Yuanji Feng and Caina Xu. Their work appears in journals such as Journal of Controlled Release, Macromolecular Bioscience, ACS Applied Materials & Interfaces, Dalton Transactions and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.